BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33296336)

  • 1. Atypical course of COVID-19 in patient with Bruton agammaglobulinemia.
    Milošević I; Jovanović J; Stevanovic O
    J Infect Dev Ctries; 2020 Nov; 14(11):1248-1251. PubMed ID: 33296336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked agammaglobulinemia - first case with Bruton tyrosine kinase mutation from Pakistan.
    Zaidi SK; Qureshi S; Qamar FN
    J Pak Med Assoc; 2017 Mar; 67(3):471-473. PubMed ID: 28304004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia.
    Conte WL
    Mult Scler Relat Disord; 2020 Sep; 44():102315. PubMed ID: 32593144
    [No Abstract]   [Full Text] [Related]  

  • 4. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia.
    Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS
    Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible COVID-19 reinfection in a patient with X-linked agammaglobulinaemia.
    Loh SY; Bassett J; Hoodless EJ; Walshaw M
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
    Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM
    Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma.
    Gomes AMC; Farias GB; Trombetta AC; Godinho-Santos A; Parreira I; Gonçalves HD; Simões ML; Aguiar P; Deveza MM; Inácio J; Sousa AE; da Silva SL
    Eur J Haematol; 2023 Feb; 110(2):209-212. PubMed ID: 36208028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
    Pereira NMD; Heath PT; Doerholt K; Almario-Hernandez AF; Gilmour C; Drysdale SB
    Pediatr Infect Dis J; 2021 Dec; 40(12):e472-e474. PubMed ID: 34596628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [X-linked agammaglobulinemia in adults. Clinical evolution].
    Giorgetti OB; Paolini MV; Oleastro MM; Fernández Romero DS
    Medicina (B Aires); 2016; 76(2):65-70. PubMed ID: 27135842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy.
    Sag AT; Saka E; Ozgur TT; Sanal O; Ayvaz DC; Elibol B; Kurne AT
    Cogn Behav Neurol; 2014 Sep; 27(3):155-9. PubMed ID: 25237746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-Linked agammaglobulinemia in a child with Klinefelter's syndrome.
    Cochino AV; Janda A; Ravcukova B; Plaiasu V; Ochiana D; Gherghina I; Freiberger T
    J Clin Immunol; 2014 Feb; 34(2):142-5. PubMed ID: 24477949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton's agammaglobulinemia.
    Rise N; Touborg T; Lundsted DH; Dalager-Pedersen M; Mogensen TH
    Front Immunol; 2022; 13():1057065. PubMed ID: 36505407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
    Staehelin F; Kühne T
    Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
    Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cells and COVID-19: Lessons From Patients With Agammaglobulinemia and the Study of Functional B-Cell Polymorphisms.
    Speletas M; Raftopoulou S; Farmaki E; Gatselis N; Germanidis G; Mouchtouri VA; Hatzianastasiou S; Georgiadou S; Tsinti G; Tsachouridou O; Tseroni M; Metallidis S; Dalekos G; Eibel H; Hadjichristodoulou C
    J Investig Allergol Clin Immunol; 2021 Feb; 32(1):53-55. PubMed ID: 34159904
    [No Abstract]   [Full Text] [Related]  

  • 16. Leg ulcer in a patient with agammaglobulinaemia.
    Russo G; Licciardello M; Sciotto A
    Lancet Infect Dis; 2005 Jul; 5(7):460. PubMed ID: 15978532
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.
    Roschewski M; Lionakis MS; Sharman JP; Roswarski J; Goy A; Monticelli MA; Roshon M; Wrzesinski SH; Desai JV; Zarakas MA; Collen J; Rose K; Hamdy A; Izumi R; Wright GW; Chung KK; Baselga J; Staudt LM; Wilson WH
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32503877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.
    Bucciol G; Moens L; Payne K; Wollants E; Mekahli D; Levtchenko E; Vermeulen F; Tousseyn T; Gray P; Ma CS; Tangye SG; Van Ranst M; Brown JR; Breuer J; Meyts I
    J Clin Immunol; 2018 Oct; 38(7):748-752. PubMed ID: 30311057
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
    Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
    Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-Linked Agammaglobulinemia Case with TH Domain Missense Mutation in Bruton Tyrosine Kinase.
    Agrebi N; Gentilcore G; Grivel JC; Alkhayer G; Hassoun J; Hassan A; Adeli M; Lo B
    J Clin Immunol; 2021 May; 41(4):825-828. PubMed ID: 33501616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.